CHAPTER 14. Cosmetic Safety [108980. - 108982.]

Cal. Health and Safety Code - HSC 14.

in effect

Cal. Health and Safety Code - HSC § 108980. Section 108980.

(a) Commencing January 1, 2025, a person or entity shall not manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains any of the following intentionally added ingredients: (1) Dibutyl phthalate (CAS no. 84-74-2). (2) Diethylhexyl phthalate (CAS no. 117-81-7). (3) Formaldehyde (CAS no. 50-00-0). (4) Paraformaldehyde (CAS no. 30525-89-4). (5) Methylene glycol (CAS no. 463-57-0). (6) Quaternium-15 (CAS no. 51229-78-8). (7) Mercury (CAS no. 7439-97-6). (8) Isobutylparaben (CAS no. 4247-02-3). (9) Isopropylparaben (CAS no. 4191-73-5). (10) m-Phenylenediamine and its salts (CAS no. 108-45-2). (11) o-Phenylenediamine and its salts (CAS no. 95-54-5). (12) The following per- and polyfluoroalkyl substances (PFAS) and their salts: (A) Perfluorooctane sulfonate (PFOS); heptadecafluorooctane-1-sulfonic acid (CAS no. 1763-23-1). (B) Potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate (CAS no. 2795-39-3). (C) Diethanolamine perfluorooctane sulfonate (CAS 70225-14-8). (D) Ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate (CAS 29081-56-9). (E) Lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate (CAS 29457-72-5). (F) Perfluorooctanoic acid (PFOA)(CAS no. 335-67-1). (G) Ammonium pentadecafluorooctanoate (CAS no. 3825-26-1). (H) Nonadecafluorodecanoic acid (CAS no. 355-76-2). (I) Ammonium nonadecafluorodecanoate (CAS no. 3108-42-7). (J) Sodium nonadecafluorodecanoate (CAS no. 3830-45-3). (K) Perfluorononanoic acid (PFNA)(CAS no. 375-95-1). (L) Sodium heptadecafluorononanoate (CAS no. 21049-39-8). (M) Ammonium perfluorononanoate (CAS no. 4149-60-4). (b) Except as provided in paragraph (2) of subdivision (f), commencing January 1, 2027, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains any of the following intentionally added ingredients: (1) Lily aldehyde (CAS no. 80-54-6). (2) Acetaldehyde (CAS no. 75-07-0). (3) Cyclohexylamine (CAS no. 108-91-8). (4) Cyclotetrasiloxane (CAS no. 556-67-2). (5) Phytonadione (CAS no. 84-80-0). (6) Sodium perborate (CAS no. 15120-21-5). (7) Styrene (CAS no. 100-42-5). (8) Trichloroacetic acid (CAS no. 76-03-9). (9) Tricresyl phosphate (CAS no. 1330-78-5). (10) Vinyl acetate (CAS no. 108-05-4). (11) 2-Chloracetamide (CAS no. 79-07-2). (12) Allyl isothiocyanate (CAS no. 57-06-7). (13) Anthraquinone (CAS no. 84-65-1). (14) Malachite green (CAS no. 569-64-2). (15) Oil from the seeds of Laurus nobilis L. (CAS no. 84603-73-6). (16) Pyrogallol (CAS no. 87-66-1). (17) C.I. disperse blue 1 (CAS no. 2475-45-8). (18) Trisodium nitrilotriacetate (CAS no. 5064-31-3). (19) The following boron substances: (A) Perboric acids: (i) Sodium salt (CAS no. 11138-47-9). (ii) Sodium salt, monohydrate (CAS no. 12040-72-1). (iii) Sodium perborate monohydrate (CAS no. 10332-33-9). (B) Boric acid (CAS nos. 10043-35-3 and 11113-50-1). (C) Borates, tetraborates, octaborates, and boric acid salts and esters, including all of the following: (i) Disodium octaborate anhydrous (CAS no. 12008-41-2). (ii) Disodium octaborate tetrahydrate (CAS no. 12280-03-4). (iii) 2-Aminoethanol, monoester with boric acid (CAS no. 10377-81-8). (iv) 2-Hydroxypropyl ammonium dihydrogen orthoborate (CAS no. 68003-13-4). (v) Potassium borate, boric acid potassium salt (CAS no. 12712-38-8). (vi) Trioctyldodecyl borate. (vii) Zinc borate (CAS no. 1332-07-6). (viii) Sodium borate, disodium tetraborate anhydrous; boric acid, sodium salt (CAS no. 1330-43-4). (ix) Tetraboron disodium heptaoxide, hydrate (CAS no. 12267-73-1). (x) Orthoboric acid, sodium salt (CAS no. 13840-56-7). (xi) Disodium tetraborate decahydrate; borax decahydrate (CAS no. 1303-96-4). (xii) Disodium tetraborate pentahydrate; borax pentahydrate (CAS no. 12179-04-3). (20) C.I. disperse blue 3 (CAS no. 2475-46-9). (21) Basic green 1 (CAS no. 633-03-4). (22) Basic blue 7 (CAS no. 2390-60-5). (23) 3(or5)-((4-(benzylmethylamino)phenyl)azo)-1,2 -(or1,4)-dimethyl-1H-1,2,4-triazolium and its salts (CAS nos. 89959-98-8 and 12221-69-1). (24) Basic violet 4 (CAS no. 2390-59-2). (25) Basic blue 3 (CAS no. 33203-82-6). (26) Basic blue 9 (CAS no. 61-73-4). (27) Musk ambrette (CAS no. 83-66-9). (28) Musk tibetene (CAS no.145-39-1). (29) Musk moskene (CAS no. 116-66-5). (30) Musk xylene (CAS no. 81-15-2). (c) (1) Commencing January 1, 2027, a person or entity shall not manufacture, sell, deliver, hold, or offer for sale in commerce a cosmetic product that contains more than 1.4 percent in fine fragrance products, 0.56 percent in eau de toilette, 0 percent in oral products, and 0.042 percent in all other products of musk ketone (CAS no. 81-14-1). (2) “Oral products” means a cosmetic product that is intended to be applied on teeth or the mucous membranes of the oral cavity. (d) If a cosmetic product made through manufacturing processes intended to comply with this chapter contains a technically unavoidable trace quantity of an ingredient listed in subdivision (a) or (b) and that trace quantity stems from impurities of natural or synthetic ingredients, the manufacturing process, storage, or migration from packaging, that trace quantity shall not cause the cosmetic product to be in violation of this section. (e) For purposes of this section, “ingredient” has the same meaning as defined in Section 111791.5. (f) (1) Commencing January 1, 2027, a person or entity that manufactures, sells, delivers, holds, or offers for sale in commerce a vaginal suppository product containing intentionally added boric acid (CAS nos. 10043-35-3 and 11113-50-1) shall include on the product label the following statement: “WARNING: IT IS RECOMMENDED TO CONSULT WITH A DOCTOR BEFORE USE, particularly if you have sensitivity in your lower pelvis or abdomen, a sexually transmitted disease (STD), pelvic inflammatory disease (PID), vaginal bleeding, sores, ulcerations, nausea, fever, or chills. Do not use on broken or irritated skin. Stop use and contact a doctor if symptoms persist or worsen, or if you experience irritation, burning, bleeding, or cramping. NOT FOR ORAL CONSUMPTION. FOR VAGINAL USE ONLY. DO NOT USE IF PREGNANT, TRYING TO CONCEIVE, OR NURSING. IF YOU BECOME PREGNANT WHILE USING THIS PRODUCT, DISCONTINUE USE IMMEDIATELY. If swallowed, get medical help or contact Poison Control Center immediately. Some boric acid suppository products may break down a condom—ensure product has completely dissolved before having sex.” (2) Commencing January 1, 2035, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce a vaginal suppository product that contains intentionally added boric acid (CAS nos. 10043-35-3 and 11113-50-1). (3) Paragraphs (1) and (2) shall not apply to a vaginal suppository product containing intentionally added boric acid (CAS nos. 10043-35-3 and 11113-50-1) if the product becomes regulated as a drug by the United States Food and Drug Administration.

Cal. Health and Safety Code - HSC § 108981. Section 108981.

The Legislature finds and declares all of the following: (a) Perfluoroalkyl and polyfluoroalkyl substances, a class of chemicals known as “PFAS,” are highly toxic and highly persistent in the environment. (b) PFAS are referred to as “forever chemicals” because they are extremely resistant to degradation in the natural environment, including the water, the soil, the air, and our bodies, because of their carbon-fluorine bond, one of the strongest bonds known in nature. (c) PFAS have been linked by scientific, peer-reviewed research to severe health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption, including interference with vaccines. (d) PFAS are used to provide stain, grease, and water resistance in a wide variety of consumer products, including food packaging, cookware, cleaning products, rugs and carpets, home furnishings, household linens, childcare products, and apparel, including outdoor wear and beauty and personal care products. (e) Because of the widespread use of PFAS, they can be found in water, air, fish, and soil at locations across the nation and the globe. Due to this widespread use, the federal Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey (NHANES) found PFAS in the blood of 97 percent of Americans, suggesting virtually ubiquitous exposure of Californians to these highly toxic chemicals. This widespread use has also resulted in broad PFAS dispersal in indoor and outdoor environments, including the PFAS contamination of the drinking water of approximately 16 million Californians, particularly in disadvantaged communities, of breast milk, and of indoor and outdoor air. (f) The European Union has committed in its “Chemicals Strategy for Sustainability Towards a Toxic-Free Environment” to phasing out PFAS unless a specific use is proven essential for society, in part because the costs from exposure to PFAS in Europe have been estimated between fifty-two billion euros (€52,000,000,000) and eighty-four billion euros (€84,000,000,000) per year, or between fifty-eight billion dollars ($58,000,000,000) and ninety-five billion dollars ($95,000,000,000). (g) The Legislature has acted to protect Californians from exposure to PFAS by recently enacting laws to ban firefighting foams, paper-based food packaging, and specified children’s products containing any of the full class of PFAS chemicals. The Legislature has also acted to restrict the total PFAS concentration in products labeled compostable, and in products labeled recyclable. In 2020, the Legislature also acted to ban the use of 13 specified PFAS substances in cosmetic products. (h) PFAS chemicals have been found in a wide variety of cosmetics and personal care products, including foundation, mascara, lipstick, and various eye and face products. (i) The Legislature intends to protect the health of Californians and the environment by prohibiting the sale or distribution of any beauty or personal care product containing PFAS chemicals.

Cal. Health and Safety Code - HSC § 108981.5. Section 108981.5.

Beginning January 1, 2025, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS).

Cal. Health and Safety Code - HSC § 108982. Section 108982.

For purposes of this chapter, the following terms have the following definitions: (a) “Cosmetic product” means an article for retail sale or professional use intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance. (b) “Perfluoroalkyl and polyfluoroalkyl substances” or “PFAS” means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom. (c) “Intentionally added PFAS” means either of the following: (1) PFAS chemicals that a manufacturer has intentionally added to a product and that have a functional or technical effect on the product. (2) PFAS chemicals that are intentional breakdown products of an added chemical. (d) “Product label” means a display of written, printed, or graphic matter upon a cosmetic product or upon its immediate container.

Source: CA Legislative Counsel Bulk DataURL: https://downloads.leginfo.legislature.ca.gov/pubinfo_2025.zipFetched: 6/27/2026